Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Varela, Rosario
DOB:	03-MAY-1956 (Age: 69)
Gender:	male
Address:	Ronda de Graciela Llorens 62 46001 Valencia (Spain)
ID:	8295-992682-3 (ECI)

Report
Date:	13-NOV-2016

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Centro Privado de Educación Especial Parálisis Cerebral Infantil Calle Alboraya 4 46010 Valencia (Spain)

Specimen
Collected:	13-NOV-2016

Chemistry

Test	13-NOV-2016	Reference Range	Unit
Glucose [Mass/volume] in Blood	84.0	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	13.5	7 - 18	mg/dL
Creatinine [Mass/volume] in Blood	3.4 H	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.7	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	143.0	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.5	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	101.5	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	21.4 L	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	7.4	6.6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	4.4	3.5 - 5.5	g/dL
Globulin [Mass/volume] in Serum by calculation	3.4 L	20 - 39	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	0.2	0.2 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	43.6	39 - 117	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	20.4	10 - 40	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	18.2	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	199.7	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	146.0	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	146.6 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	64.2 H	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significantly elevated creatinine, suggesting impaired renal function. Total CO₂ is slightly low, possibly indicating mild metabolic acidosis. LDL cholesterol is high, increasing cardiovascular risk, while HDL is also elevated, which is generally protective. Other parameters, including glucose, liver enzymes, and electrolytes, are within normal limits. Recommend further evaluation of renal function and cardiovascular risk management.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows significantly elevated creatinine, suggesting impaired renal function. Total CO₂ is slightly low, possibly indicating mild metabolic acidosis. LDL cholesterol is high, increasing cardiovascular risk, while HDL is also elevated, which is generally protective. Other parameters, including glucose, liver enzymes, and electrolytes, are within normal limits. Recommend further evaluation of renal function and cardiovascular risk management.